臨床研究等提出・公開システム

Human Phenotype Project Japan:
Collection of deep phenotype data for the establishment of a research platform
(HPP JP)

HPP JP

Shin Koga

SBS Shizuoka Health Promotion Center

3-1-1 Toro, Suruga-ku, Shizuoka City

hematojack@gmail.com

Yumiko Hirayama

Pheno.AI Japan Ltd.

3-14-24 Hiroo, Shibuya-ku Tokyo

+81-354033560

yhirayama@csb.co.jp

Recruiting

Feb. 27, 2025

Observational

1) Men and women aged 40-69 at pre-screening
2) Individuals who are capable of visiting the CTC at baseline and have a will to continue to visit the CTC throughout the follow-up period at pre-screening
3) Individuals who are able and willing to sign a consent form at the time of the baseline visit to the CTC
4) Own a smartphone and being able to use it at pre-screening

1) Individuals who are pregnant or within 2 months after pregnancy
2) Individuals who are on infertility treatment or within 2 months after the last infertility treatment (women only)
3) Individuals who have malignancy, recurrent or metastatic, that is either untreated or undergoing treatment, or a certain period of time has not passed since the last treatment at pre-screening (for chemotherapy, less than 1 year from the date of the last administration; for radiotherapy, less than 2 months from the day of the last exposure)
4) Individuals who have a history of chronic or acute hepatitis
5) Individuals who have a history of HIV infection, hepatitis B or C virus infection
6) Individuals who have diagnosed with liver cirrhosis
7) Individuals who are under dialysis treatment
8) Individuals who have poorly controlled disease or symptoms (with unstable symptoms and clinical laboratory test results despite treatments)
9) Individuals who are not capable of continued participation in this study due to impaired cognitive, intellectual, or mental function

Both

none

Development of medical conditions based on participant's self-reporting

+81-3-6265-6106

Jan. 30, 2025

none